Journal: Scientific Reports
Article Title: Immunoprognostic model of lung adenocarcinoma and screening of sensitive drugs
doi: 10.1038/s41598-022-11052-8
Figure Lengend Snippet: CMap database drug screening and cytological activity validation. ( a ) Optimal compounds and their structures screened from the CMap database. ( b ) DMSO solvent toxicity assay. ( c ) Inhibition rate of the resveratrol compound on A549 cells. ( d ) Inhibition rate of the methotrexate compound on A549 cells. ( e ) Inhibition rate of the phenoxybenzamine compound on A549 cells.
Article Snippet: We further prepared a solution of resveratrol (Lot#:C12594500, Macklin, China), methotrexate (Lot#: C12150088, Macklin, China), phenoxybenzamine (Lot#: C11947938, Macklin, China), and thiostrepton.
Techniques: Drug discovery, Activity Assay, Biomarker Discovery, Solvent, Inhibition